It is possible to go into remission with myeloma multiple times but it is not guaranteed. The number of times a person can go into remission with myeloma depends on a variety of factors including the type of treatment (including chemotherapy, radiation, and other therapies) used, the overall health of the patient, any underlying medical conditions, and the progression of the cancer.
Individuals typically respond differently to treatments, so some may enter and remain in remission for several years, while others may experience recurring episodes. With the advancement of new personalised treatments, such as CAR-T therapy and other immunotherapies, we are beginning to see an increase in the number of successful remissions for individuals with multiple myeloma.
While the number of remissions can vary greatly and is not a guarantee, the American Cancer Society notes that those who adhere to a regular screening and monitoring plan, follow their treatment plans, and remain aware of their changing health status can help to maximise the number of successful remissions.
Table of Contents
How many times can multiple myeloma relapse?
Multiple myeloma is a type of cancer that affects plasma cells in the bone marrow. The disease is characterized by an abnormal accumulation of these cells and can lead to serious complications, including anemia, fatigue, and frequent infections.
The number of times a patient can relapse with multiple myeloma depends on several factors, such as the stage at which the disease was diagnosed, the type and extent of treatment received, and the response to treatment.
Generally, patients with early stage multiple myeloma tend to have a better chance of successful treatment and fewer relapses than those who are diagnosed with later stage multiple myeloma.
In terms of possible relapses, the exact number of relapses experienced by a patient will depend on their individual disease course and the treatment approach that is chosen. Some patients may only experience one relapse, while others can relapse multiple times before achieving remission.
Some of the possible factors that can influence the likelihood of relapse include the presence of high-risk disease factors, the patient’s treatment response, the effectiveness of the therapy, as well as the type and duration of the treatment.
Additional factors that may play a role in the recurrence of multiple myeloma include the patient’s age at diagnosis, the amount of time spent in remission, and the presence of disease-related genetic abnormalities.
It is important to understand that there is no one-size-fits-all approach when it comes to predicting the number of relapses that a patient can experience. However, with the right combination of treatments and lifestyle modification, multiple myeloma can be successfully managed and the risk of relapse can be significantly reduced.
How long can you live with relapsed multiple myeloma?
It is difficult to determine an exact amount of time someone can live with relapsed multiple myeloma, as it can differ based on individual characteristics, such as responsiveness to treatment, overall health, and in some cases luck.
That said, some people can survive for many years after being diagnosed with relapsed multiple myeloma. For some, the disease is stable and can go into remission for many months or even years. Research has also demonstrated that people with relapsed multiple myeloma who receive more aggressive treatments, such as a stem-cell transplant, may experience longer survival rates than those whose treatment is less aggressive.
Additionally, newer treatments, such as immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, have made it possible for some people to live even longer with the disease. Ultimately, the goal of each treatment is to delay the progression of the disease and maximize quality of life.
What is considered relapse in multiple myeloma?
Relapse in multiple myeloma is defined as a return of the disease after a period of remission, which is typically at least three months. A patient may experience a relapse in multiple myeloma if they experience any of the following symptoms: rapid increase in monoclonal protein (M protein) levels in blood tests; bone lesions in bone scans; or new bone lesions or expansile lesions in MRI studies.
Other signs that may be indicative of a relapse include anemia, recurrent infections, hypercalcemia, and kidney failure. In addition, a decrease in the number of healthy blood cells (white blood cells and platelets) can also indicate a relapse.
Treatment for a relapse in multiple myeloma typically includes chemotherapy, radiation, and/or immunotherapy, depending on the severity of the case. In some cases, a stem cell transplant or a combination of treatments may also be recommended.
What is the most frequent cause of death in a patient with multiple myeloma?
The most frequent cause of death in a patient with multiple myeloma is complications due to the disease itself, such as infections, kidney failure, and anemia. Multiple myeloma is a type of cancer that affects white blood cells, which are involved in the body’s natural defense system.
Because of this, it can weaken the immune system and make it difficult for the body to fight off infections and other health issues. Anemia is also a common complication of multiple myeloma, which can lead to fatigue, breathlessness, and increased risk of infection.
Kidney failure is also a major concern with this type of cancer, as it can cause further complications. All of these complications can contribute to an increased risk of death in patients with multiple myeloma.
How do you know when multiple myeloma is getting worse?
When multiple myeloma is getting worse, there are certain signs and symptoms that you may experience. For example, you may experience increased bone pain, particularly in the ribs, hips, and spine—often worse at night—or even fractures in the affected bones.
You may also experience increased fatigue, shortness of breath, anemia, and more frequent or increased infections. If you experience any of these signs or symptoms, it is important to contact your doctor and discuss them since they could be indicative of multiple myeloma progression.
Additional tests may be necessary to make a definitive diagnosis.
What is the median survival time for a patient diagnosed with multiple myeloma?
The median survival time for a patient diagnosed with multiple myeloma varies based on a variety of factors, such as the stage at which it is diagnosed, the overall health of the patient, the type of treatment received, and the stage of the disease.
According to the American Cancer Society, the median survival time for people with multiple myeloma is 4 years. But, this number varies widely depending on when the disease is diagnosed, the type of treatment given, and the patient’s overall health.
For people whose multiple myeloma has not yet spread, the median survival time is approximately 6 to 8 years. For those who are diagnosed too late and already have multiple myeloma in their bones, the median survival time can be as short as 8 to 10 months.
People who have more advanced stages may also not survive past 5 years.
In general, the earlier the disease is diagnosed and treated, the better the prognosis and the longer the patient is likely to survive. People who have been diagnosed with multiple myeloma should always talk to their doctor about the best course of treatment for their individual case.
When is multiple myeloma no longer treatable?
Multiple myeloma is an incurable type of cancer, and it is generally considered no longer treatable when it becomes resistant to the treatments prescribed. This can be caused by the cancer cells having mutations that prevent chemotherapy drugs or other treatments from reducing the cancer’s size or preventing it from spreading further.
With the advancement of treatments for multiple myeloma, some people will get years of remission and symptom-free stages, but if the cancer stops responding to treatments, and the person is no longer a candidate for additional therapies, multiple myeloma is typically viewed as no longer being treatable.
In some cases where the treatments don’t work, and the cancer has not spread too much, doctors may estimate the number of months or years an individual might live, so the patient can still receive palliative care, if desired.
Does multiple myeloma come back after remission?
Yes, although remission is a goal for people living with multiple myeloma, it is not a cure. Myeloma can come back after remission, even many years later. This means that multiple myeloma is a chronic condition for which recurrent episodes of active disease can occur.
It is important to be aware that multiple myeloma can come back even after long stretches of remission. Regular monitoring after remission is necessary to detect any signs of relapse early so that appropriate treatment can be started.
Your doctor can advise you on what they recommend for long-term surveillance. Factors such as age, genetics, previously used treatments, and other individual factors may influence the suggested surveillance protocol.
Regardless of the follow-up plan, it is important to be aware of potential signs and symptoms of relapse. These may include an increase in myeloma protein levels, tiredness, loss of appetite, unintentional weight loss, night sweats, and bone pain.
If these or other concerning symptoms arise, contact your doctor immediately. Early detection and rapid response are essential to have the best chance at achieving a second remission.
What are the types of remission in multiple myeloma?
There are three types of remission in multiple myeloma: complete remission (CR), partial remission (PR), and very good partial remission (VGPR).
Complete remission is the highest form of remission and is when there is an absence of both cancer cells and symptoms. In this stage, all tests results, such as imaging scans, blood tests, and physical examination results, show no evidence of cancer.
Partial remission occurs when there is a decrease in the number of cancer cells compared to the initial diagnosis. It is measured as a percentage reduction in cancer cells and usually is less than 90%.
In this stage, some symptoms of multiple myeloma such as anemia and bone lesions may persist.
Very Good Partial Remission (VGPR) is between a partial and complete remission and is defined as a 90% or greater reduction in the number of cancer cells. Similar to partial remission, some symptoms may be slower to go away.
It is important to keep in mind that remission is not a cure for multiple myeloma. It is a period of decreased cancer activity that may eventually end with a recurrence of the cancer. It is important for individuals with multiple myeloma to be monitored closely by a myeloma specialist.
Can Stage 3 myeloma go into remission?
Yes, Stage 3 myeloma can go into remission. The specific definition of remission for Stage 3 myeloma can vary from person to person, but typically it means that a patient’s myeloma has gone away or been brought to a low level that can be managed and kept under control.
Remission for Stage 3 myeloma might include a significant reduction in symptoms such as anemia, frequent infections, fatigue, bone pain, night sweats, and bone fractures.
Stage 3 myeloma can typically be brought into remission through several different treatment plans, including stem cell transplant, chemotherapy, radiation therapy, biological therapy, and stem cell therapy.
These treatments generally aim to reduce the number of cancer cell in the body, which can then be monitored by a health care provider to ensure that the myeloma remains in a state of remission. Ultimately, remissions can greatly improve the quality of life for patients with Stage 3 myeloma, allowing them to have fewer symptoms and a higher chance of survival.
How long can myeloma remission last?
Myeloma remission can be temporary or permanent, and can last anywhere from a few months to many years. In some cases, remission can last indefinitely, and individuals in that situation may be able to lead relatively normal, healthy lives.
On the other hand, some people experience intermittent remissions and may experience periods when their myeloma is active, followed by periods of remission. In general, the longer your remission lasts, the more likely it is that it will be permanent, but this is not always the case.
A combination of treatments such as chemotherapy, radiation, stem cell transplants, and biological therapies can be effective in improving the duration and quality of remission. Your doctor can help you determine the best course of treatment for you.
How close are we to a cure for multiple myeloma?
It is difficult to say how close we are to a cure for multiple myeloma, but considerable progress has been made in the past few decades. Multiple myeloma is a type of blood cancer, and there is still much to learn about its causes, symptoms, and treatment options.
However, researchers have made substantial progress in understanding this disease and identifying effective treatments, which has improved survival rates.
Currently, the average survival rate for multiple myeloma is five years; this has nearly doubled since the mid-1990s. In recent years, promising new treatments such as immunotherapy, targeted therapy, and combination therapy have emerged.
These treatments are showing positive results in some cases, with some patients achieving remission or even cures in particularly fortunate cases.
Although there is not yet a single universal cure for multiple myeloma, there is a wide range of treatment options available, and the prognosis is getting better with each passing year. With continuing research and improvements in treatments, there is great hope that a cure for multiple myeloma will be found in the near future.
